Related Experiment Video
Updated: Nov 3, 2025

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene
Published on: December 31, 2014
Oncogenic Potential of the Dual-Function Protein MEX3A
Marcell Lederer1, Simon Müller1, Markus Glaß1
1Charles Tanford Protein Center, Faculty of Medicine, Institute of Molecular Medicine, Section for Molecular Cell Biology, Martin Luther University Halle-Wittenberg, Kurt-Mothes-Str. 3a, 06120 Halle, Germany.
Abstract:
MEX3A belongs to the MEX3 (Muscle EXcess) protein family consisting of four members (MEX3A-D) in humans. Characteristic for MEX3 proteins is their domain structure with 2 HNRNPK homology (KH) domains mediating RNA binding and a C-terminal really interesting new gene (RING) domain that harbors E3 ligase function. In agreement with their domain composition, MEX3 proteins were reported to modulate both RNA fate and protein ubiquitination. MEX3 paralogs exhibit an oncofetal expression pattern, they are severely downregulated postnatally, and re-expression is observed in various malignancies. Enforced expression of MEX3 proteins in various cancers correlates with poor prognosis, emphasizing their oncogenic potential. The latter is supported by MEX3A's impact on proliferation, self-renewal as well as migration of tumor cells in vitro and tumor growth in xenograft studies.
Insights
Muscle EXcess (MEX3) proteins, including MEX3A, are involved in RNA binding and ubiquitination. Their re-expression in cancers correlates with poor prognosis and promotes tumor growth.
Area of Science:
- Molecular Biology
- Cancer Research
- Protein Biochemistry
Background:
- MEX3 proteins (MEX3A-D) possess RNA-binding (KH domains) and E3 ligase (RING domain) functions.
- These proteins exhibit an oncofetal expression pattern, downregulated postnatally but re-expressed in malignancies.
- Re-expression of MEX3 proteins in cancer is linked to poor patient prognosis.
Purpose of the Study:
- To investigate the role of MEX3A in cancer progression.
- To understand the functional implications of MEX3A's dual RNA-binding and E3 ligase activities.
Main Methods:
- Analysis of MEX3A domain structure and function.
- In vitro studies on tumor cell proliferation, self-renewal, and migration.
- In vivo xenograft studies to assess tumor growth.
Main Results:
- MEX3A's domain structure supports its roles in RNA fate modulation and protein ubiquitination.
- Enforced MEX3A expression in cancer correlates with poor prognosis.
- MEX3A enhances tumor cell proliferation, self-renewal, migration, and xenograft tumor growth.
Conclusions:
- MEX3A possesses oncogenic potential, contributing to tumor progression through modulation of RNA and protein.
- Targeting MEX3A may offer a therapeutic strategy for various malignancies.
More Related Videos
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
09:58Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
Related Concept Videos
Induced Pluripotent Stem Cells
Somatic...
Abnormal Proliferation
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Master Transcription Regulators
Mitogens and the Cell Cycle
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...